anti-SARS-CoV-2 immunoglobulin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-SARS-CoV-2 immunoglobulin, covering 2020-10-05 to 2020-10-05. Get the full timeline:
Most recent: Clinical Trial Update: TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19 [Phase 1, Phase 2]